Methamphetamine Use Disorder and Inflammation: A Case-Control Study

키워드

참고문헌 (44)

1. Köroğlu E, "Diagnostic and statistical manual of mental disorders", pp.231~290 (2013), Hekimler Yayın Birliği
2. Moszczynska A, "Current and emerging treatments for methamphet amine use disorder", Curr Neuropharmacol, 19, pp.2077~2091 (2021)
3. Yang X, "The main molecu lar mechanisms underlying methamphetamine-induced neurotoxicity and implications for pharmacological treatment", Front Mol Neurosci, 11, pp.186~ (2018)
4. Huckans M, "Plasma in f lammatory factors are associated with anxiety, depression, and cogni tive problems in adults with and without methamphetamine depen dence : an exploratory protein array study", Front Psychiatry, 6, pp.178~ (2015)
5. Salamanca SA, "Impact of methamphetamine on infection and immunity", Front Neurosci, 8, pp.445~ (2015)
6. Peerzada H, "Methamphetamine administration modifies leukocyte proliferation and cytokine production in murine tissues", Immunobiology, 218, pp.10631068~ (2013)
7. Debnath M, "Recent advances in psychoneuroimmunology : inflammation in psy chiatric disorders", Transl Neurosci, 2, pp.121~137 (2011)
8. Morcuende A, "Inflam matory biomarkers in addictive disorders", Biomolecules, 11, pp.1824~ (2021)
9. Kulu M, "Inflammation levels in patients with alco hol and substance use disorders", Cukurova Med J, 46, pp.1558~1565 (2021)
10. Soder HE, "Elevated neutrophil to lymphocyte ratio in older adults with cocaine use disorder as a marker of chronic inflammation", Clin Psycho pharmacol Neurosci, 18, pp.32~40 (2020)
11. Dadouli K, "Neutrophil-to-lymphocyte, monocyte-to-lympho cyte, platelet-to-lymphocyte ratio and systemic immune-inflammatory index in different states of bipolar disorder", Brain Sci, 12, pp.1034~ (2022)
12. Citirik M, "MPV may reflect subcinical platelet activation in diabetic patients with and without diabetic retinopathy", Eye(Lond), 29, pp.376~379 (2015)
13. Qian Y, "Association of platelet count and plateletcrit with nerve conduction function and peripheral neuropathy in patients with type 2 diabetes mellitus", J Diabe tesInvestig, 12, pp.1835~1844 (2021)
14. Yang R, "Prognostic value of sys temic immune-inflammation index in cancer : a meta-analysis", J Can cer, 9, pp.3295~3302 (2018)
15. Felger JC, "What does plasma CRP tell us about peripheral and cen tral inflammation in depression?", Mol Psychiatry, 25, pp.1301~1311 (2020)
16. Efe TH, "The prognostic value of the monocyte", HDL ratio in predicting short term mortality in patients with acute pulmonary embolism, 2016, pp.19, 149~153
17. Zhong JH, "Prognostic role of systemic immune inflammation index in solid tumors : a systematic review and meta analysis", Oncotarget, 8, pp.75381~75388 (2017)
18. Cıcek E, "Increased neutrophil lymphocyte and platelet-lymphocyte ratios in male heroin addicts : a prospective controlled study", Clin Psychopharmacol Neurosci, 16, pp.190~196 (2018)
19. Demir B, "Neutrophil-lym phocyte ratio and platelet-lymphocyte ratio in methamphetamine use disorder", Psychiatr Clin Psychopharmacol, 31, pp.34~39 (2021)
20. Osório FL, "Clinical validity and intrarater and test-retest re liability of the structured clinical interview for DSM-5-clinician ver sion(SCID-5-CV)", Psychiatry Clin Neurosci, 73, pp.754~760 (2019)
21. Elbir M, "Adaptation and reliability of the structured clinical interview for DSM 5-disorders - clinician version (SCID-5", CV) to the Turkish language, 2019, pp.30, 51~56
22. Wallace C, "Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia", Drug Alcohol Rev, 28, pp.592~599 (2009)
23. McKetin R, "Health service utilisation attributable to methamphetamine use in Australia : patterns, predictors and national impact", Drug Alcohol Rev, 37, pp.196~204 (2018)
24. Paulus MP, "Neurobiology, clinical presentation, and treat ment of methamphetamine use disorder : a review", JAMA Psychiatry, 77, pp.959~966 (2020)
25. Kilic E, "Evaluation of neutrophil to lymphocyte and platelet to lymphocyte ra tios in rheumatoid arthritis", Dicle Med J, 43, pp.241~247 (2016)
26. Bulut NS, "The severity of inflammation in major neuropsychiatric disorders : comparison of neutrophil-lympho cyte and platelet-lymphocyte ratios between schizophrenia, bipolar ma nia, bipolar depression, major depressive disorder, and obsessive com pulsive disorder", Nord J Psychiatry, 75, pp.624~632 (2021)
27. Nazari A, "Effect of meth amphetamine exposure on the plasma levels of endothelial-derived mi croparticles", Drug Alcohol Depend, 186, pp.219~225 (2018)
28. Papageorgiou M, "Meth amphetamine and its immune-modulating effects", Maturitas, 121, pp.13~21 (2019)
29. Buchanan JB, "A neurotoxic regimen of methamphetamine exacerbates the febrile and neuroinflammatory re sponse to a subsequent peripheral immune stimulus", J Neuroinflammation, 7, pp.82~ (2010)
30. Kohno M, "Neuroinflammation in addiction : a review of neuroimaging stud ies and potential immunotherapies", Pharmacol Biochem Behav, 179, pp.34~42 (2019)
31. Rajavashisth TB, "Decreased prevalence of diabetes in marijuana users : cross-sectional data from the national health and nutrition examination survey(NHANES)III", BMJ Open, 2, pp.e000494~ (2012)
32. Nazir S, "Interaction between high-density lipoproteins and inflammation:function matters more than concentration!", Adv Drug Deliv Rev, 159, pp.94~119 (2020)
33. Wei Y, "Investigation of systemic immune-inflammation index, neutrophil", high-density lipoprotein ratio, lymphocyte, high-density lipoprotein ratio as indicators of inflammation in patients with schizo phrenia and bipolar disorder, pp.Front Psychiatry, 2022[DOI]
34. Li Y, "Elevated monocyte-to-HDL cho lesterol ratio predicts post-stroke depression", Front Psychiatry, 13, pp.902022~ (2022)
35. Huang H, "Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer", Sci Rep, 9, pp.3284~ (2019)
36. Uyar B, "Effects of major depressive disorder on mono cytes, high-density lipoprotein(HDL)and monocyte to HDL ratio : a case-control study", Psychiatr Danub, 34, pp.687~694 (2022)
37. Zhou L, "Inflammation and coronary heart disease risk in patients with depression in China mainland : a cross-sectional study", Neuropsychiatr Dis Treat, 16, pp.81~86 (2020)
38. Wang J, "Peripheral inflammatory biomarkers of methamphetamine withdrawal patients based on the neuro-inflam mation hypothesis : the possible improvement effect of exercise", Front Psychiatry, 12, pp.795073~ (2021)
39. Pogorzelska K, "Characteristics of platelet indices and their prognostic significance in selected medical condition-a systematic review", Adv Med Sci, 65, pp.310~315 (2020)
40. Lappin JM, "Stroke and methamphetamine use in young adults : a review", J Neurol Neurosurg Psychiatry, 88, pp.10791091~ (2017)
41. Schürer S, "Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy", JACC Heart Fail, 5, pp.435~445 (2017)
42. Ahearn OC, "Chemokines, cytokines and sub stance use disorders", Drug Alcohol Depend, 220, pp.108511~ (2021)
43. Li MJ, "Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder", Drug Alcohol Depend, 206, pp.107776~ (2020)
44. Linker KE, "Glial mechanisms underlying sub stance use disorders", Eur J Neurosci, 50, pp.2574~2589 (2019)

관련 논문AI추천